insulet.com - PODD Profit before deduction of interest, taxes, depreciation and amortization
Insulet Corporation (PODD) is expanding the global reach of its Omnipod wireless systems, reducing its reliance on the US market. A subscription model for disposable devices ensures stable revenue, while technological superiority guarantees customer loyalty. Historical EBITDA_Co data confirm these successes, with the latest parameter standing at 713.87, helping investors timely recognize the cash flow consolidation phase.
Summary analytical data breakdowns for Insulet (PODD)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Insulet Corporation|PODD - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Insulet Corp|PODD - Company Aggregate Debts|Debts to Book Value Insulet|PODD - Company Long-Term Debts|Company Short-Term Indebtedness Insulet|Interim Coverage Ratio insulet.com
- earnings and market multiples details:
PODD - Net Profit|Future Profit Insulet Corporation|PODD - P/E Multiple|Forward P/E Multiple insulet.com|PODD - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Insulet|PODD - Operating profit before deduction of amortization|Earnings per share for the trailing year Insulet|PODD - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months insulet.com|PODD - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Insulet Corporation
Summary company analytics:Insulet Corporation
Insulet Corporation specializes in the development of high-tech medical devices for diabetes therapy. This indicator captures the actual cash flow from core operations, excluding the impact of depreciation and taxes. The trend in EBITDA_Co allows for the rapid tracking of margin compression amid competition or product recall risks. The stability of the curve confirms sales resilience under the external pressure of new drugs. This metric serves as a leading signal of fundamental business degradation or growth.
Who Insulet Corporation competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|ZBH: Operating profit EBITDA|Profit before interest, taxes and amortization The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - Operating profit EBITDA|Operating profit before amortization GMED (NuVasive)|Operating profit before deduction of amortization TMDX (TransMedics)|ATEC (atecspine.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Artivion AORT|ENOV - Operating profit before deduction of amortization|Integra - Operating profit EBITDA|Profit before interest, taxes and amortization Establishment Labs Inc|BBNX: Operating profit EBITDA|Operating profit before amortization IRMD|EMBC (Embecta) - Operating profit EBITDA|Tandem Diabetes Care Inc (TNDM) - Operating income before deduction of amortization|Operating profit EBITDA AXGN|Operating profit before deduction of amortization SI-BONE Medical SIBN|Operating profit EBITDA OFIX (Orthofix Medical Inc.)|Operating profit EBITDA bioventus.com BVS|KIDS - Profit before payment of interest, taxes and amortization|TMCI: Profit before payment of interest, taxes and amortization|SRTA (Strata Critical Medical Corp) - Operating profit before deduction of amortization|Carlsmed Medical - Income before deduction of interest, taxes and amortization|RXST (RxSight, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization ClearPoint CLPT|Profit before payment of interest, taxes and amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Operating profit before depreciation charges|Sight Sciences, Inc - Operating profit before deduction of amortization|Operating profit EBITDA orchestrabiomed.com OBIO|Anika - Operating profit EBITDA|Operating income before deduction of amortization inspiremd.com NSPR|zhjmedical.com (ZJYL) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VANI (Vivani Medical)|Profit before payment of interest, taxes and amortization Xtant Medical Holdings, Inc.|Operating profit before deduction of amortization NeuroOne Medical Technologies Corp. (NMTC)|Operating profit EBITDA MODD|MYO - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Envoy Medical COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|TNON: Operating profit EBITDA|LFWD - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Autonomix Medical Inc.|Operating profit before amortization IVF (INVO Bioscience)|Profit before payment of interest, taxes and amortization Bone Biologics Corporation (BBLG)|Operating income before deduction of amortization Axonics, Inc|BIOLASE, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Dynatronics Corp DYNT|FNA - Profit before payment of interest, taxes and amortization|INVO: Profit before payment of interest, taxes and amortization
